Fanny Delettre/innovativetherapiesdays.com
Oct 24, 2026, 05:53
Fanny Delettre: Sharing Clinical Research for the Continuous Improvement of Transfusion Practices
Fanny Delettre, Director of EFS Bourgogne–Franche-Comté at EFS, shared a post on LinkedIn:
“Happy to have had the opportunity to present the ÉCLAT clinical trial during the Autumn Day of the French Society of Blood Transfusion (SFTS), in the exceptional setting of Val-de-Grâce.
Clinical evaluation of our practices is essential to ensure transfusion safety, improve the quality of care and best meet patient needs.
An enriching moment of sharing and exchanges in the service of the continuous improvement of our transfusion practices.
Thank you Bourgogne–Franche-Comté Region for supporting this clinical research.”
Stay updated with Hemostasis Today.
-
Oct 24, 2026, 05:55Flora Peyvandi: A New Way of Thinking About Microthrombosis and Organ Dysfunction
-
Oct 24, 2026, 05:54Dwana Calhoun: How Emerging Tobacco Products Affect Hemostasis
-
Oct 24, 2026, 05:51Raising Awareness of Acquired Haemophilia A Through Jenny’s Story – Haemophilia Foundation Australia
-
Oct 24, 2026, 05:50Narender Kumar: Honoured to Receive the THANZ International Travel Grant 2026 at Blood 2026
-
Oct 24, 2026, 05:46James Posada: Demonstrating the Benefits of Nuclease Therapy in Ischemic Stroke
-
Oct 24, 2026, 05:44Juan Luis Fernández Masip: Reconnecting With the Australia and New Zealand Hematology Community at Blood 2026
-
Oct 24, 2026, 05:43No One Should Navigate Von Willebrand Disease Alone – EHC
-
Oct 24, 2026, 05:42Joseph R. Shaw: Thrombin Generation as a Tool for Coagulation Phenotyping in Critically Ill Patients
-
Oct 24, 2026, 05:39Ani Mebalds: Advancing the Availability of Cryopreserved Blood Products at AABB